Arrowhead Pharmaceuticals
ARWR
#2139
Rank
NZ$15.35 B
Marketcap
NZ$109.66
Share price
1.56%
Change (1 day)
247.58%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): NZ$0.26 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.82 Billion. In 2024 the company made an earning of -NZ$1.02 Billion a decrease over its 2023 earnings that were of -NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.26 B-126.08%
2024 -NZ$1.02 Billion112.45%
2023 -NZ$0.48 Billion87.79%
2022 -NZ$0.26 Billion-20.1%
2021 -NZ$0.32 Billion67.59%
2020 -NZ$0.19 Billion-347.53%
2019 NZ$76.46 M-245.59%
2018 -NZ$52.52 Million-13.17%
2017 -NZ$60.49 Million-52.28%
2016 -NZ$0.13 Billion-16.57%
2015 -NZ$0.16 Billion30.32%
2014 -NZ$0.12 Billion171.62%
2013 -NZ$42.93 Million16.56%
2012 -NZ$36.83 Million107.53%
2011 -NZ$17.75 Million
2008 -NZ$62.51 Million-8.07%
2007 -NZ$67.99 Million70.37%
2006 -NZ$39.91 Million122.51%
2005 -NZ$17.94 Million147.41%
2004 -NZ$7.25 Million2002.28%
2003 -NZ$0.35 Million-85.61%
2002 -NZ$2.4 Million1371.97%
2001 -NZ$0.17 Million-13.45%
2000 -NZ$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$54.57 B 22,893.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.3 Billion-2,332.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-52.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion-183.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.21 B-7.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-NZ$0.19 Billion-176.72%๐Ÿ‡บ๐Ÿ‡ธ USA